🔴 Insmed is trading 5% down today after CFO Sara Bonstein's October 30 departure

Insmed is now trading 5.07% lower at $105.49 as investors focus on CFO Sara Bonstein’s planned October 30 departure.

• The company has begun searching for a successor and said Bonstein’s departure is unrelated to disagreements over accounting, financial statements, controls, or operations.
• Insmed reaffirmed its 2026 revenue guidance.
• The S&P 500 and Nasdaq were slightly higher, while the Dow was lower.